Bolt Biotherapeutics
Willie Quinn is currently the President & CEO at Bolt Biotherapeutics, Inc., a company focused on developing pharmaceutical products for cancer treatment. Prior to Bolt Bio, Quinn held leadership roles in various organizations including A Foundation Building Strength, Sunesis Pharmaceuticals, Midnight Pharma, Neurogastrx, Bullet Biotechnology, and Jazz Pharmaceuticals. Quinn has a strong background in finance, business development, and corporate operations. Willie holds an MBA from Stanford University Graduate School of Business, along with multiple degrees in Japanese literature and language.
This person is not in any teams
Bolt Biotherapeutics
7 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.